140 related articles for article (PubMed ID: 22363859)
21. Kinetics of the superficial perfusion and temperature in connection with photodynamic therapy of basal cell carcinomas using esterified and non-esterified 5-aminolaevulinic acid.
Pålsson S; Gustafsson L; Bendsoe N; Soto Thompson M; Andersson-Engels S; Svanberg K
Br J Dermatol; 2003 Jun; 148(6):1179-88. PubMed ID: 12828747
[TBL] [Abstract][Full Text] [Related]
22. Monitoring of photobleaching in photodynamic therapy using fluorescence spectroscopy.
Sharwani A; Alharbi FA
Gulf J Oncolog; 2014 Jul; 1(16):79-83. PubMed ID: 25316396
[TBL] [Abstract][Full Text] [Related]
23. Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma.
Smucler R; Vlk M
Lasers Surg Med; 2008 Feb; 40(2):153-8. PubMed ID: 18306163
[TBL] [Abstract][Full Text] [Related]
24. Photodynamic therapy for the prevention and treatment of actinic keratosis/squamous cell carcinoma in solid organ transplant recipients: a systematic review and meta-analysis.
Liew YCC; De Souza NNA; Sultana RG; Oh CC
J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):251-259. PubMed ID: 31394005
[TBL] [Abstract][Full Text] [Related]
25. Combined carbon dioxide laser with photodynamic therapy for nodular and superficial basal cell carcinoma.
Shokrollahi K; Javed M; Aeuyung K; Ghattaura A; Whitaker IS; O'Leary B; James W; Murison M
Ann Plast Surg; 2014 Nov; 73(5):552-8. PubMed ID: 23407256
[TBL] [Abstract][Full Text] [Related]
26. Daylight-mediated photodynamic therapy of basal cell carcinomas - an explorative study.
Wiegell SR; Skødt V; Wulf HC
J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):169-75. PubMed ID: 23294223
[TBL] [Abstract][Full Text] [Related]
27. Non-invasive pulsed ultrasound quantification of the resolution of basal cell carcinomas after photodynamic therapy.
Allan E; Pye DA; Levine EL; Moore JV
Lasers Med Sci; 2002; 17(4):230-7. PubMed ID: 12417976
[TBL] [Abstract][Full Text] [Related]
28. An ultrasound analysis of the response of Gorlin syndrome-related and sporadic basal cell carcinomas to aminolaevulinic acid photodynamic therapy.
Loncaster JA; Moore JV; Allan D; Allan E
Photodiagnosis Photodyn Ther; 2005 Jun; 2(2):149-55. PubMed ID: 25048674
[TBL] [Abstract][Full Text] [Related]
29. Photodynamic therapy with methyl-5-aminolevulinate for basal cell carcinoma: A systematic review and meta-analysis.
Wang BC; Fu C; Qin L; Zeng XY; Liu Q
Photodiagnosis Photodyn Ther; 2020 Mar; 29():101667. PubMed ID: 31978564
[TBL] [Abstract][Full Text] [Related]
30. Systemic photodynamic therapy with Photofrin for naevoid basal cell carcinoma syndrome-A pilot study.
Madan V; Loncaster J; Allan D; Lear J; Sheridan L; Leach C; Allan E
Photodiagnosis Photodyn Ther; 2005 Dec; 2(4):273-81. PubMed ID: 25048869
[TBL] [Abstract][Full Text] [Related]
31. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic therapy in the management of basal cell carcinoma: Retrospective evaluation of outcome.
Jerjes W; Hamdoon Z; Hopper C
Photodiagnosis Photodyn Ther; 2017 Sep; 19():22-27. PubMed ID: 28442314
[TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response.
Fantini F; Greco A; Del Giovane C; Cesinaro AM; Venturini M; Zane C; Surrenti T; Peris K; Calzavara-Pinton PG
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):896-901. PubMed ID: 21054566
[TBL] [Abstract][Full Text] [Related]
34. Topical methyl aminolevulinate.
Siddiqui MA; Perry CM; Scott LJ
Am J Clin Dermatol; 2004; 5(2):127-37; discussion 138-40. PubMed ID: 15109276
[TBL] [Abstract][Full Text] [Related]
35. Periorbital skin cancers subjected to mTHPC-photodynamic therapy: A prospective study.
Hamdoon Z; Jerjes W; Hopper C
Skin Res Technol; 2020 May; 26(3):338-342. PubMed ID: 31777106
[TBL] [Abstract][Full Text] [Related]
36. Daylight photodynamic therapy: experience in the treatment of actinic keratosis in the San Gallicano Institute (Rome) and a review of literature.
Carbone A; Sperduti I; De Simone P; Piemonte P; Ferrari A; Buccini P; Silipo V; Iorio A; Frascione P; Eibenschutz L
G Ital Dermatol Venereol; 2020 Jun; 155(3):312-319. PubMed ID: 29368865
[TBL] [Abstract][Full Text] [Related]
37. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
[TBL] [Abstract][Full Text] [Related]
38. Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas.
Nikkels AF; Piérard-Franchimont C; Nikkels-Tassoudji N; Bourguignon R; Piérard GE
Acta Clin Belg; 2005; 60(5):227-34. PubMed ID: 16398319
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic therapy as a treatment option for multiple pigmented basal cell carcinoma: Long-term follow-up results.
Salvio AG; Requena MB; Stringasci MD; Bagnato VS
Photodiagnosis Photodyn Ther; 2021 Mar; 33():102154. PubMed ID: 33348074
[TBL] [Abstract][Full Text] [Related]
40. Daylight photodynamic therapy with methyl aminolaevulinate in patients with actinic keratoses: a preliminary experience in Southern Italy.
Fai D; Romano I; Fai C; Cassano N; Vena GA
G Ital Dermatol Venereol; 2016 Apr; 151(2):154-9. PubMed ID: 25279493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
